Cagrilintide
Cagrilintide
A potent, long-acting amylin analogue for significant appetite reduction and weight loss.
Cagrilintide is a long-acting amylin analogue developed for the treatment of obesity. It mimics the natural hormone amylin, which is involved in regulating food intake and body weight. By activating amylin receptors in the brain, Cagrilintide induces a powerful sense of fullness, leading to reduced caloric consumption and significant weight loss.
Key Benefits
Mechanism of Action
Cagrilintide functions as a dual agonist for amylin and calcitonin receptors, primarily in the area postrema of the brainstem. This activation enhances satiety signals, slows gastric emptying, and suppresses the secretion of glucagon. The result is a profound and sustained reduction in appetite, which drives weight loss by decreasing overall energy intake.
Dosing Guidelines
Typical Dose
0.3 mg to 2.4 mg, titrated upwards
Frequency
1x weekly
Duration
20-26+ weeks
Note: Administered via subcutaneous injection. Dosing must be escalated slowly over several weeks (e.g., doubling the dose every 2-4 weeks) to manage nausea and improve tolerability.
Research & Studies
A comprehensive overview of Cagrilintide's mechanism, benefits, side effects, and its role in metabolic health.
Read Full ResearchA 2021 study in The Lancet showed that weekly Cagrilintide resulted in a dose-dependent weight loss of up to 10.8% over 26 weeks.
Read Full ResearchClinical trials show that combining Cagrilintide with Semaglutide (CagriSema) leads to superior weight loss compared to either peptide alone.
Read Full ResearchPotential Side Effects
Reported side effects may include:
- • Nausea (most common, especially during dose increases)
- • Vomiting and/or diarrhea
- • Decreased appetite (an intended effect that can be excessive)
- • Constipation
- • Mild injection site reactions (redness, itching)
- • Occasional dizziness or fatigue
This information is for research purposes only. Always consult with a healthcare professional.
Popular Stacking Options
Cagrilintide + Semaglutide
The definitive stack. Combines Cagrilintide's amylin-driven appetite suppression with Semaglutide's GLP-1 effects on satiety and gastric emptying for a powerful, synergistic impact on weight loss.
Shop this stackCagrilintide + Ipamorelin
May help preserve lean muscle mass during a significant caloric deficit induced by Cagrilintide by promoting a natural GH pulse without elevating cortisol.
Shop this stackFrequently Asked Questions
How is Cagrilintide different from Semaglutide?
They target different hormonal pathways. Cagrilintide mimics amylin to primarily slash appetite. Semaglutide mimics GLP-1 to slow digestion, improve insulin release, and also signal fullness to the brain. They are combined because their effects are complementary, producing much greater weight loss than either can alone.
Is the nausea from Cagrilintide manageable?
Yes, for most people. Nausea is the most common side effect, but it's managed by starting with a very low dose and increasing it slowly over many weeks. This 'titration' allows your body to adapt. The nausea usually lessens or disappears after a few weeks at a stable dose.
Can I use Cagrilintide to build muscle?
No, Cagrilintide is not an anabolic peptide. Its purpose is to create a caloric deficit by suppressing appetite, which leads to weight loss. During aggressive weight loss, you risk losing muscle, which is why some researchers pair it with peptides that help preserve lean mass, like Ipamorelin or Tesamorelin.
How quickly does Cagrilintide work?
You will likely feel the appetite-suppressing effects within the first week or two of starting. Noticeable weight loss typically follows and accumulates steadily over months. Clinical trials show the most significant results occur over 20-26 weeks of consistent use.
Ready to Purchase Cagrilintide?
Get pharmaceutical-grade Cagrilintide from Peptide Palace with 99%+ purity, third-party lab testing, and same-day dispatch.
Buy Cagrilintide Now